US Stock MarketDetailed Quotes
ZNTL Zentalis Pharmaceuticals
- 4.470
- +0.110+2.52%
Close Jul 26 16:00 ET
317.43MMarket Cap-1371P/E (TTM)
4.620High4.300Low437.71KVolume4.420Open4.360Pre Close1.95MTurnover0.85%Turnover RatioLossP/E (Static)71.01MShares29.03052wk High0.69P/B230.27MFloat Cap3.27052wk Low--Dividend TTM51.51MShs Float87.190Historical High--Div YieldTTM7.34%Amplitude3.270Historical Low4.443Avg Price1Lot Size
About Zentalis Pharmaceuticals Company
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
Company Profile
SymbolZNTL
Company NameZentalis Pharmaceuticals
Listing DateApr 3, 2020
Issue Price18.00
Founded2014
CEODr. Kimberly L. Blackwell, M.D.
MarketNASDAQ
Employees168
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10275 Science Center Drive,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-263-4333
Websitehttp://www.zentalis.com
Company Executives
- Name
- Position
- Salary
- Dr. Kimberly L. Blackwell, M.D.
- Director and Chief Executive Officer
- 12.85M
- Dr. Kyle Rasbach, PhD,Pharm.D.
- Chief Business Officer
- --
- Andrea Paul
- Chief Legal Officer and Corporate Secretary
- 2.63M
- Dr. Mark Lackner, PhD
- Chief Scientific Officer
- --
- Cam S. Gallagher
- Director, President, Interim Chief Financial Officer and Treasurer
- 8.58M
- Dr. Diana F. Hausman, M.D.
- Chief Medical Officer
- 906.98K
- Vincent Vultaggio
- Vice President, Finance and Interim Principal Accounting Officer
- --
- David M. Johnson
- Chairman of the Board
- 617.78K
- Dr. Jan Skvarka, PhD
- Independent Director
- 515.22K
- Dr. Enoch Kariuki, Pharm.D.
- Independent Director
- 516.97K
- Karan S. Takhar
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg